StockData
Lipella Pharmaceuticals Inc. logo

Lipella Pharmaceuticals Inc. (LIPO) stock

LIPOOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2025, quarter ended Sep 30, 2025Last filing: 10-Q on Nov 14, 2025Score 6/30
$0.00+0.00 (0.00%)

Close on Oct 19, 2026Market cap $2.27KP/E –Yield –

Lipella Pharmaceuticals shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Lipella Pharmaceuticals's shares outstanding was 5M at Sep 30, 2025. For fiscal 2024 it was 1M, up 39.7% from the year before.

Annual shares outstanding

PeriodPeriod endValueChange
FY2024Dec 31, 20241M+39.7%
FY2023Dec 31, 20231M+47.8%
FY2022Dec 31, 20221M+19.1%
FY2021Dec 31, 20210M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2025Sep 30, 20255M+306.5%
Q2 FY2025Jun 30, 20254M+352.9%
Q1 FY2025Mar 31, 20252M+125.6%
Q4 FY2024Dec 31, 20241M+43.0%
Q3 FY2024Sep 30, 20241M+55.6%
Q2 FY2024Jun 30, 20241M+32.4%
Q1 FY2024Mar 31, 20241M+27.0%
Q4 FY2023Dec 31, 20231M+53.8%
Q3 FY2023Sep 30, 20231M+40.1%
Q2 FY2023Jun 30, 20231M+48.6%
Q1 FY2023Mar 31, 20231M+48.6%
Q4 FY2022Dec 31, 20221M–
Q3 FY2022Sep 30, 20221M–
Q2 FY2022Jun 30, 20220M–
Q1 FY2022Mar 31, 20220M–

More Lipella Pharmaceuticals figures

See a number that looks wrong?